These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25209224)

  • 1. Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full-term infants.
    Yahia S; Shabaan AE; Gouida M; El-Ghanam D; Eldegla H; El-Bakary A; Abdel-Hady H
    Eur J Pediatr; 2015 Apr; 174(4):459-64. PubMed ID: 25209224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates.
    Tatli MM; Minnet C; Kocyigit A; Karadag A
    Mutat Res; 2008 Jun; 654(1):93-5. PubMed ID: 18534897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jaundice, phototherapy and DNA damage in full-term neonates.
    Ramy N; Ghany EA; Alsharany W; Nada A; Darwish RK; Rabie WA; Aly H
    J Perinatol; 2016 Feb; 36(2):132-6. PubMed ID: 26583945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of DNA damage and plasma catalase activity in healthy term hyperbilirubinemic infants receiving phototherapy.
    Karakukcu C; Ustdal M; Ozturk A; Baskol G; Saraymen R
    Mutat Res; 2009; 680(1-2):12-6. PubMed ID: 19712750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in total serum bilirubin during phototherapy in late preterm and term infants with non-haemolytic hyperbilirubinemia.
    Dani C; Becciani S; Pratesi S
    Early Hum Dev; 2019 Apr; 131():41-44. PubMed ID: 30831388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phototherapy, hyperbilirubinemia and genotoxicity in newborns.
    Karadag A; Demirin H; Dogan DG; Aslan M; Tatli MM
    Mutat Res; 2010 Mar; 697(1-2):68; author reply 69. PubMed ID: 20096372
    [No Abstract]   [Full Text] [Related]  

  • 7. Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial.
    Sachdeva M; Murki S; Oleti TP; Kandraju H
    Eur J Pediatr; 2015 Feb; 174(2):177-81. PubMed ID: 25005717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Fenofibrate as an adjuvant to phototherapy in pathological unconjugated hyperbilirubinemia in neonates: a randomized control trial.".
    Awad MH; Amer S; Hafez M; Nour I; Shabaan A
    J Perinatol; 2021 Apr; 41(4):865-872. PubMed ID: 33070152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of recommended blood tests for neonates requiring phototherapy for hyperbilirubinemia.
    Besser I; Perry ZH; Mesner O; Zmora E; Toker A
    Isr Med Assoc J; 2010 Apr; 12(4):220-4. PubMed ID: 20803881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Increased Genotoxic Risk in Lymphocytes from Phototherapy-Treated Hyperbilirubinemic Neonates.
    Mesbah-Namin SA; Shahidi M; Nakhshab M
    Iran Biomed J; 2017 May; 21(3):182-9. PubMed ID: 27869251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal hyperbilirubinemia in infants with G6PD c.563C > T Variant.
    Moiz B; Nasir A; Khan SA; Kherani SA; Qadir M
    BMC Pediatr; 2012 Aug; 12():126. PubMed ID: 22906047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperbilirubinemia in Term Newborns Needing Phototherapy within 48 Hours after Birth in a Japanese Birth Center.
    Tsujimae S; Yoshii K; Yamana K; Fujioka K; Iijima K; Morioka I
    Kobe J Med Sci; 2018 Sep; 64(1):E20-E25. PubMed ID: 30282894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A multicenter randomized controlled study on the efficacy and safety of Yinzhihuang oral solution for the treatment of neonatal indirect hyperbilirubinemia in term newborn infants].
    Clinical Research Collaborative Group of Yinzhihuang Oral Solution
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):663-8. PubMed ID: 22176900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enduring controversies in the management of hyperbilirubinemia in preterm neonates.
    Watchko JF; Jeffrey Maisels M
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):136-40. PubMed ID: 20060792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clofibrate in non-hemolytic indirect hyperbiliru-binemia in full term neonates.
    Eghbalian F; Pourhossein A; Zandevakili H
    Indian J Pediatr; 2007 Nov; 74(11):1003-6. PubMed ID: 18057680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates.
    Yücesoy E; Demir Yenigürbüz F; Ateş H; Tüzün F; Duman N; Özkan H; Ören H
    Blood Coagul Fibrinolysis; 2024 Jul; 35(5):227-231. PubMed ID: 38973516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.
    Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE
    World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyperbilirubinemia.
    Berkwitt A; Osborn R; Grossman M
    Hosp Pediatr; 2015 Feb; 5(2):74-8. PubMed ID: 25646199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single vs. double phototherapy in the treatment of full-term newborns with nonhemolytic hyperbilirubinemia.
    Silva I; Luco M; Tapia JL; Pérez ME; Salinas JA; Flores J; Villaroel L
    J Pediatr (Rio J); 2009; 85(5):455-8. PubMed ID: 19830352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia: a randomized controlled trial.
    Serce O; Gursoy T; Ovali F; Karatekin G
    Am J Perinatol; 2015 Feb; 30(2):137-42. PubMed ID: 24915562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.